Literature DB >> 31904366

Sodium-hydrogen exchanger regulatory factor-1 (NHERF1) confers salt sensitivity in both male and female models of hypertension in aging.

Sathnur Pushpakumar1, Asrar Ahmad2, Corey J Ketchem3, Pedro A Jose4, Edward J Weinman5, Utpal Sen1, Eleanor D Lederer6, Syed J Khundmiri7.   

Abstract

Hypertension is a risk factor for premature death and roughly 50% of hypertensive patients are salt-sensitive. The incidence of salt-sensitive hypertension increases with age. However, the mechanisms of salt-sensitive hypertension are not well understood. We had demonstrated decreased renal sodium‑hydrogen exchanger regulatory factor 1 (NHERF1) expression in old salt-resistant F344 rats. Based on those studies we hypothesized that NHERF1 expression is required for the development of some forms of salt-sensitive hypertension. To address this hypothesis, we measured blood pressure in NHERF1 expressing salt-sensitive 4-mo and 24-mo-old male and female Fischer Brown Norway (FBN) rats male and female 18-mo-old NHERF1 knock-out (NHERF1-/-) mice and wild-type (WT) littermates on C57BL/6J background after feeding high salt (8% NaCl) diet for 7 days. Our data demonstrate that 8% salt diet increased blood pressure in both male and female 24-mo-old FBN rats but not in 4-mo-old FBN rats and in 18-mo-old male and female WT mice but not in NHERF1-/- mice. Renal dopamine 1 receptor (D1R) expression was decreased in 24-mo-old rats, compared with 4-mo-old FBN rats. However, sodium chloride cotransporter (NCC) expression increased in 24-mo-old FBN rats. In FBN rats, age had no effect on NaK ATPase α1 and NKCC2 expression. By contrast, high salt diet increased the renal expressions of NKCC2, and NCC in 24-mo-old FBN rats. High salt diet also increased NKCC2 and NCC expression in WT mice but not NHERF1-/- mice. Our data suggest that renal NHERF1 expression confers salt sensitivity with aging, associated with increased expression of sodium transporters.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Kidney; NHERF1; Salt sensitive hypertension; Transporters

Mesh:

Substances:

Year:  2020        PMID: 31904366      PMCID: PMC7015806          DOI: 10.1016/j.lfs.2019.117226

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  58 in total

Review 1.  The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.

Authors:  Ines Armando; Prasad Konkalmatt; Robin A Felder; Pedro A Jose
Journal:  Transl Res       Date:  2014-07-25       Impact factor: 7.012

2.  Renal ENaC subunit, Na-K-2Cl and Na-Cl cotransporter abundances in aged, water-restricted F344 x Brown Norway rats.

Authors:  Y Tian; S Riazi; O Khan; J D Klein; Y Sugimura; J G Verbalis; C A Ecelbarger
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

Review 3.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

4.  NHERF1 mutations and responsiveness of renal parathyroid hormone.

Authors:  Zoubida Karim; Bénédicte Gérard; Naziha Bakouh; Rohia Alili; Christine Leroy; Laurent Beck; Caroline Silve; Gabrielle Planelles; Pablo Urena-Torres; Bernard Grandchamp; Gérard Friedlander; Dominique Prié
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

Review 5.  Salt sensitivity and systemic hypertension in the elderly.

Authors:  M B Zemel; J R Sowers
Journal:  Am J Cardiol       Date:  1988-06-15       Impact factor: 2.778

6.  Human GRK4γ142V Variant Promotes Angiotensin II Type I Receptor-Mediated Hypertension via Renal Histone Deacetylase Type 1 Inhibition.

Authors:  Zheng Wang; Chunyu Zeng; Van Anthony M Villar; Shi-You Chen; Prasad Konkalmatt; Xiaoyan Wang; Laureano D Asico; John E Jones; Yu Yang; Hironobu Sanada; Robin A Felder; Gilbert M Eisner; Matthew R Weir; Ines Armando; Pedro A Jose
Journal:  Hypertension       Date:  2015-12-14       Impact factor: 10.190

7.  Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells.

Authors:  Xiaoliang Jiang; Prasad Konkalmatt; Yu Yang; John Gildea; John E Jones; Santiago Cuevas; Robin A Felder; Pedro A Jose; Ines Armando
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

8.  Dietary sodium induces a redistribution of the tubular metabolic workload.

Authors:  Khalil Udwan; Ahmed Abed; Isabelle Roth; Eva Dizin; Marc Maillard; Carla Bettoni; Johannes Loffing; Carsten A Wagner; Aurélie Edwards; Eric Feraille
Journal:  J Physiol       Date:  2017-10-15       Impact factor: 5.182

Review 9.  American Heart Association High Blood Pressure Protocol 2017: A Literature Review.

Authors:  Asad Ali; Muhammad Abu Zar; Ahmad Kamal; Amber E Faquih; Chandur Bhan; Waleed Iftikhar; Muhammad Bilal Malik; Malik Qistas Ahmad; Nouman Safdar Ali; Shahzad Ahmed Sami; Fnu Jitidhar; Abbas M Cheema; Annum Zulfiqar
Journal:  Cureus       Date:  2018-08-29

10.  NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.

Authors:  Ran Meng; Qiong Qin; Ying Xiong; Yan Wang; Junfang Zheng; Yuan Zhao; Tao Tao; Qiqi Wang; Hua Liu; Songlin Wang; Wen G Jiang; Junqi He
Journal:  Oncotarget       Date:  2016-08-23
View more
  2 in total

1.  PPAR-α knockout leads to elevated blood pressure response to angiotensin II infusion associated with an increase in renal α-1 Na+/K+ ATPase protein expression and activity.

Authors:  Syed J Khundmiri; Carolyn M Ecelbarger; Joycemary Amponsem; Hong Ji; Kathryn Sandberg; Dexter L Lee
Journal:  Life Sci       Date:  2022-03-01       Impact factor: 5.037

2.  Sex-specific adaptations to high-salt diet preserve electrolyte homeostasis with distinct sodium transporter profiles.

Authors:  Diana L Torres-Pinzon; Donna L Ralph; Luciana C Veiras; Alicia A McDonough
Journal:  Am J Physiol Cell Physiol       Date:  2021-10-06       Impact factor: 4.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.